Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for Methotrexate-induced Liver Injury in Rheumatic Diseases
NCT06277635Recruiting
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Start
- Feb 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in drug induced liver injury (DILI) comparing Silymarin Group with Placebo Group (2 arms). Primary endpoint: AST or ALT > 1X ULN at 12 weeks. Started Feb 2024; status: recruiting.
02
Drugs
silymarin
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT06277635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06277635.